文献速递肾移植

高尿酸血症对肾移植长期结局的影响:FAVORIT研究分析

Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
PubMed 文献 · Am J Kidney Dis · 2017-08-09

该研究为FAVORIT试验的事后队列分析,纳入3,512例有基线尿酸浓度的肾移植受者,中位随访3.9年。未调整分析中尿酸浓度与心血管事件、死亡和移植失败显著相关,但多变量调整后关联不再显著,提示尿酸并非独立危险因素。

要点

  • 肾移植受者中,尿酸浓度与心血管事件、死亡和移植失败无独立关联。
  • 尿酸与eGFR及传统危险因素强相关,可能解释其非独立性。
  • 临床不应仅基于尿酸水平预测移植后不良结局。

核心结论

  • 肾移植后尿酸浓度与心血管事件、死亡率或移植失败无独立关联。

研究设计与样本

  • FAVORIT研究的事后队列分析,纳入3,512例有基线尿酸浓度的肾移植受者。
  • 中位随访3.9年(IQR 3.0-5.3),评估尿酸与结局的关联。

主要发现

  • 未调整分析中尿酸浓度与心血管事件、死亡和移植失败均显著相关。
  • 完全调整多变量模型后,尿酸与心血管事件(P=0.5)、死亡(P=0.09)和移植失败(P=0.1)的关联均不显著。
  • 尿酸浓度与eGFR强相关,可能是关联减弱的解释之一。

临床怎么用

  • 肾移植受者中,尿酸水平不宜单独用于预测心血管事件、死亡或移植失败风险。

局限性

  • 研究未获知参与者使用降尿酸药物的情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated uric acid concentration is associated with higher rates of cardiovascular (CV) morbidity and mortality in the general population. It is not known whether hyperuricemia increases the risk for CV death or transplant failure in kidney transplant recipients. STUDY DESIGN: Post hoc cohort analysis of the FAVORIT Study, a randomized controlled trial that examined the effect of homocysteine-lowering vitamins on CV disease in kidney transplantation. SETTING & PARTICIPANTS: Adult recipients of kidney transplants in the United States, Canada, or Brazil participating in the FAVORIT Study, with hyperhomocysteinemia, stable kidney function, and no known history of CV disease. PREDICTOR: Uric acid concentration. OUTCOMES: The primary end point was a composite of CV events. Secondary end points were all-cause mortality and transplant failure. Risk factors included in statistical models were age, sex, race, country, treatment assignment, smoking history, body mass index, presence of diabetes mellitus, history of CV disease, blood pressure, estimated glomerular filtration rate (eGFR), donor type, transplant vintage, lipid concentrations, albumin-creatinine ratio, and uric acid concentration. Cox proportional hazards models were fit to examine the association of uric acid concentration with study end points after risk adjustment. RESULTS: 3,512 of 4,110 FAVORIT participants with baseline uric acid concentrations were studied. Median follow-up was 3.9 (IQR, 3.0-5.3) years. 503 patients had a primary CV event, 401 died, and 287 had transplant failure. In unadjusted analyses, uric acid concentration was significantly related to each outcome. Uric acid concentration was also strongly associated with eGFR. The relationship between uric acid concentration and study end points was no longer significant in fully adjusted multivariable models (P=0.5 for CV events; P=0.09 for death, and P=0.1 for transplant failure). LIMITATIONS: Unknown use of uric acid-lowering agents among study participants. CONCLUSIONS: Following kidney transplantation, uric acid concentrations are not independently associated with CV events, mortality, or transplant failure. The strong association between uric acid concentrations with traditional risk factors and eGFR is a possible explanation.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Kalil RS, Carpenter MA, Ivanova A, et al. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study. Am J Kidney Dis. 2017. PMID: 28801121. doi:10.1053/j.ajkd.2017.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。